HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

The stock markets in the US opened higher on February 4 as investors remained cautious about China’s stance on the Trump ...

In recent trading, Hcw Biologics Inc (HCWB) stock price has shown some volatility, fluctuating 92.70% over the last five trades and 42.55% over the past 30 trades. This represents a notable shift from ...

HCW Biologics Inc. has received clearance of its IND application from the FDA to initiate a first-in-human phase I trial to ...

HCW Biologics shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration ...

The ISM manufacturing PMI for the US climbed to 50.9 in January versus a revised reading of 49.2 in December and topping ...

HCW Biologics Inc. (HCWB) a clinical-stage biopharmaceutical company, Monday said that the Food and Drug Administration (FDA)has ...

MIRAMAR, Fla. - HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical company with a market capitalization of approximately $12.4 million, announced today that it has received U.S.

Outbrain is providing selected preliminary results for the fourth quarter, in line with previously issued guidance in Outbrain's November 2024 earnings call, and selected preliminary results for Teads ...

HCW Biologics (HCWB) announced that it has received clearance of its Investigational New Drug Application, IND, from the U.S. Food and Drug ...

This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...

Highlights,HCW Biologics saw a sharp rise in trading volume.,Clinical trials progress in cancer and autoimmune ...